{
    "nctId": "NCT05667532",
    "briefTitle": "The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts",
    "officialTitle": "The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1000,
    "primaryOutcomeMeasure": "To identify female MDACC patients with dense breasts who undergo contrast-enhanced mammography",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Female patients 30-75 years of age with dense breasts (ACR BI-RADS categories C and D) who undergo routine yearly mammography at participating MDACC sites\n2. Willingness to co-enroll or currently enrolled in PA17-0584\n3. Willingness to participate in the study and ability to provide informed consent\n\nExclusion Criteria:\n\n1. Self-reported new breast symptoms since last mammogram including nipple discharge, palpable mass, skin dimpling, or focal pain.\n2. Current or recent (within the prior 6 months) history of pregnancy or breast feeding\n3. Personal history of breast cancer (DCIS or invasive breast cancer)\n4. Treatment of any other type of cancer within the past 5 years excluding in-situ cervical and non-melanoma skin cancer\n5. Breast biopsy within 6 months\n6. Breast surgery within 12 months\n7. Breast MRI, MBI, or CEM performed within 24 months\n8. Known allergy to iodine-containing contrast agents\n9. History of anaphylactic reaction to any substance that required hospitalization or IV placement in a patient with no known prior uneventful exposure to iodine-based IV contrast\n10. Renal insufficiency (as defined by UTMDACC policy 3.30- attachment 1 (appendix D)",
    "sex": "FEMALE",
    "minimumAge": "30 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}